{
    "nctId": "NCT00026117",
    "briefTitle": "Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer",
    "officialTitle": "Phase III Evaluation Of Benefin Shark Cartilage In Patients With Advanced Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Colorectal Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 88,
    "primaryOutcomeMeasure": "overall survival",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Breast or colorectal primary tumor sites\n\n  * Considered incurable\n* Breast cancer patients must have disease progression after at least 2 different chemotherapy regimens (may include chemotherapy given as an adjuvant treatment)\n\nPATIENT CHARACTERISTICS:\n\nAge:\n\n* 18 and over\n\nSex:\n\n* Male or female\n\nPerformance status:\n\n* ECOG 0-2\n\nLife expectancy:\n\n* More than 3 months\n\nHepatic:\n\n* Bilirubin no greater than 3 times upper limit of normal (ULN)\n\nRenal:\n\n* Calcium less than 1.2 times ULN\n\nOther:\n\n* Not pregnant or nursing\n* Fertile patients must use effective contraception\n\nPRIOR CONCURRENT THERAPY:\n\nChemotherapy:\n\n* Concurrent chemotherapy allowed\n* No concurrent participation in a cytotoxic chemotherapy clinical trial\n\nOther:\n\n* At least 60 days since prior shark cartilage",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}